@article{NchiozemNgnitedemSperlichMatietaetal.2023,
  author    = {Nchiozem-Ngnitedem, Vaderament-Alexe and Sperlich, Eric and Matieta, Valaire Yemene and Kuete, Jenifer Reine Ngnouzouba and Kuete, Victor and Omer, Ejlal A. A. and Efferth, Thomas and Schmidt, Bernd},
  title     = {Synthesis and bioactivity of isoflavones from ficus carica and some non-natural analogues},
  series = {Journal of natural products : Lloydia},
  volume    = {86},
  journal   = {Journal of natural products : Lloydia},
  number    = {6},
  publisher = {American Chemical Society},
  address   = {Washington, DC},
  issn      = {0163-3864},
  doi       = {10.1021/acs.jnatprod.3c00219},
  pages     = {1520 -- 1528},
  year      = {2023},
  abstract  = {FicucariconeD (1) and its 4 '-demethyl congener 2 are isoflavones isolated from fruits of Ficus carica that share a 5,7-dimethoxy-6-prenyl-substituted A-ring. Both naturalproducts were, for the first time, obtained by chemical synthesisin six steps, starting from 2,4,6-trihydroxyacetophenone. Key stepsare a microwave-promoted tandem sequence of Claisen- and Cope-rearrangementsto install the 6-prenyl substituent and a Suzuki-Miyaura crosscoupling for installing the B-ring. By using various boronic acids,non-natural analogues become conveniently available. All compoundswere tested for cytotoxicity against drug-sensitive and drug-resistanthuman leukemia cell lines, but were found to be inactive. The compoundswere also tested for antimicrobial activities against a panel of eightGram-negative and two Gram-positive bacterial strains. Addition ofthe efflux pump inhibitor phenylalanine-arginine-beta-naphthylamide(PA beta N) significantly improved the antibiotic activity in mostcases, with MIC values as low as 2.5 mu M and activity improvementfactors as high as 128-fold.},
  language  = {en}
}